Obermatt
See Similar Stocks →

Flags

Financial distress

Celanese

NYQ:CE · US1508701034
ChemicalsX-Large

360

14
EV / EBIT78
Price / Owner Earnings81
Owner Earnings Yield1
Dividend Yield35
Price/Sales72
EV / Gross Profit30
Price/Book72
Return on Capital20
Cash Return on Capital12
Return on Equity6
EBIT Margin37
Gross Profitability3
Accruals93
Owner Earnings Margin10
Sales growth45
Profit Growth70
Long-Term EPS Growth97
Reinvestment48
Price momentum19
Debt load11
Refinancing85
Debt Payback1
Liquidity35
Analyst ratings59
Opinion Changes56
Price Target Upside100
Market mood17
Value Creation4/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Celanese doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA
IndustryChemicals
SizeX-Large
TypePublic Company
ExchangeNYSE
Founded2004
Employees4,893
Websitecelanese.com
ISINUS1508701034
Last UpdateApr 2, 2026
Index & Theme
Carbon Capture, Utilisation & Sequestration (CCUS) or (CCS)Energy StorageCleanTechAnaerobic DigestionInjection MoldingPackaging ServicesBio-based and Renewable MaterialsBiomass EnergyChemicalChemical EngineeringManufacturing

Description

Celanese Corporation operates as a global chemical and specialty materials company. The company is a global producer of high performance engineered polymers that are used in a variety of high-value applications, as well as one of the world's largest…

Analysis

Weak and unloved

Celanese Corporation scores below average on quality and is priced accordingly, a low-conviction position in either direction.

Valuation data is not available for this company.

Growth is moderate; the safety picture is fragile. The company scores 4/20 on our value-creation score: not creating value. Analysts lean positive.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
53
2023202420252026

All-time high

53

Jun 2026

All-time low

8

Jan 2024

Average rank

34

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
72
69
41
25
Price/Earnings
80
100
67
66
Price/Book
72
74
42
24
Dividend Yield
35
45
61
79
Value (overall)
77
86
56
47

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Celanese with its peers
Olin
NYQ:OLN
16
CountryUSA
IndustryChemicals
SizeMedium
Full Stock Analysis →
Trinseo
NYQ:TSE
5
CountryUSA
IndustryChemicals
SizeMedium
Full Stock Analysis →
NewMarket
NYQ:NEU
68
CountryUSA
IndustryChemicals
SizeLarge
Full Stock Analysis →
Stepan
NYQ:SCL
21
CountryUSA
IndustryChemicals
SizeMedium
Full Stock Analysis →
Huntsman
NYQ:HUN
5
CountryUSA
IndustryChemicals
SizeLarge
Full Stock Analysis →
Eastman Chemical
NYQ:EMN
41
CountryUSA
IndustryChemicals
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →